Roger Pomerantz - 15 Feb 2022 Form 4 Insider Report for CONTRAFECT Corp

Role
Chief Executive Officer, Director
Signature
/s/Michael Messinger, attorney-in-fact for Roger Pomerantz
Issuer symbol
N/A
Transactions as of
15 Feb 2022
Net transactions value
+$1,665,000
Form type
4
Filing time
17 Feb 2022, 17:18:58 UTC
Previous filing
29 Nov 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CFRX Options (Right to Buy) Award $1,665,000 +500,000 $3.33 500,000 15 Feb 2022 Common Stock 500,000 $3.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal quarterly installments with 6.25% of the total underlying shares vesting at the end of each quarter following the vesting commencement date, subject to continued service with the issuer through each vesting date.